Table 1

Baseline characteristics and biochemical assessments

Variable
Control group (n = 83)
CAD group (n = 241)
P value

Men (%)
38(45.8)
165(68.5)
<0.0001
Age (yrs)
62 ± 10
66 ± 10
0.001
Cigarette smoking (%)
11(13.3)
68(28.2)
0.007
Hypertension (%)
52(62.7)
175(72.6)
NS
Blood pressure



     Systolic (mmHg)
138 ± 21
137 ± 20
NS
     Diastolic (mmHg)
81 ± 10
79 ± 11
NS
     Hyperlipidemia (%)
47(56.6)
137(56.8)
NS
Cholesterol



     Total cholesterol (mmol/L)
4.77 ± 1.27
4.70 ± 1.15
NS
     HDL-cholesterol (mmol/L)
1.19 ± 0.30
1.13 ± 0.41
NS
     LDL-cholesterol (mmol/L)
2.80 ± 0.89
2.73 ± 0.90
NS
Triglycerides(mmol/L)
2.23 ± 1.79
2.01 ± 1.19
NS
Lipoprotein-a (g/L)
0.19 ± 0.11
0.25 ± 0.19
0.025
Apo-A (g/L)
1.29 ± 0.19
1.24 ± 0.22
NS
Apo-B (g/L)
0.94 ± 0.26
0.94 ± 0.25
NS
Glucose (mmol/L)
7.03 ± 1.88
7.28 ± 2.72
NS
Blood urea nitrogen (mmol/L)
5.49 ± 1.60
6.05 ± 2.29
0.043
Creatinine (μmol/L)
74.67 ± 16.31
92.59 ± 29.22
<0.0001
Uric acid (μmol/L)
307.9 ± 76.03
314.19 ± 83.07
NS
Glycated albumin (%)
19.37 ± 4.29
21.21 ± 5.24
0.001
Hs-CRP (mg/L)
7.37 ± 8.71
25.77 ± 30.35
<0.0001

Pu et al. Cardiovascular Diabetology 2006 5:27   doi:10.1186/1475-2840-5-27